The lab-confirmed interval of COVID-19 clusters and its application in the strength evaluation of prevention and control measures
Open Access
- 27 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 21 (1), 1-8
- https://doi.org/10.1186/s12879-021-05874-6
Abstract
The lab-confirmed interval is the date from lab confirmation in a core case (infector) to lab confirmation in a second case (infectee); however, its distribution and application are seldom reported. This study aimed to investigate the lab-confirmed interval and its application in the preliminary evaluation of the strength of disease prevention and control measures. Taking European countries and Chinese provinces outside Hubei as examples, we identified 63 infector-infectee pairs from European countries from Wikipedia, and 103 infector-infectee pairs from official public sources in Chinese provinces outside Hubei. The lab-confirmed intervals were obtained through analysis of the collected data and adopting the bootstrap method. The mean lab-confirmed interval was 2.6 (95% CI: 2.1–3.1) days for Europe and 2.6 (95% CI: 1.9–3.3) days for China outside Hubei, which were shorter than the reported serial intervals. For index patients aged ≥60 years old, the lab-confirmed interval in Europe was slightly longer (mean: 2.9; 95% CI: 2.0–3.6) and obviously longer in China outside Hubei (mean: 3.8; 95% CI: 1.9–5.5) than that for patients aged < 60 years. Investigation of the lab-confirmed interval can provide additional information on the characteristics of emergent outbreaks and can be a feasible indication to evaluate the strength of prevention and control measures. When the lab-confirmed interval was shorter than the serial interval, it could objectively reflect improvements in laboratory capacity and the surveillance of close contacts.Funding Information
- National Natural Science Foundation of China (81903407)
This publication has 22 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study GroupPublished by Cold Spring Harbor Laboratory ,2020
- Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling studyThe Lancet, 2020
- Modelling the epidemic trend of the 2019 novel coronavirus outbreak in ChinaPublished by Cold Spring Harbor Laboratory ,2020
- Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictionsPublished by Cold Spring Harbor Laboratory ,2020
- The Fight against the 2019-nCoV Outbreak: an Arduous March Has Just BegunJournal of Korean Medical Science, 2020
- The Ongoing Ebola Epidemic in the Democratic Republic of Congo, 2018–2019The New England Journal of Medicine, 2019
- Zika VirusThe New England Journal of Medicine, 2016
- Ebola Viral Disease Outbreak — West Africa, 20142014
- PoliomyelitisThe Neurohospitalist, 2014